Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: quidditch who wrote (2290)	4/13/1999 11:56:00 PM
From: BDR	Read Replies (1) of 10280

<< Thread, correct me if I'm wrong: does any of SEPR's pipeline of licensed and co-promoted or self-developed drugs deal with urinary incontinence (ICE for oxybutynin)--I didn't think so...>> From the Sepracor web site (http://www.sepracor.com/html/3.science/therap.html) Sepracor's Urology Drugs: (S)-oxybutynin - a potential treatment for urinary incontinence with potentially reduced anticholinergic side effects including dry mouth, restlessness, nausea and heart palpitations. (S)-oxybutynin will progress to Phase IIb trials in early 1999. (S)-doxazosin - a potential BPH treatment with potentially decreased orthostatic hypotension compared to Cardura®.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next